Last reviewed · How we verify
NCT02997826: BABYMILK
Effect of Infant Formula Intake on Infant Growth From 0 to 6 Months.
NA trial testing Infantil formula in Child Development in 100 participants. Completed in 30 October 2018.
30 October 2018
Quick facts
| Lead sponsor | Institut Pasteur de Lille |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 14 November 2016 |
| Primary completion | 30 October 2018 |
| Estimated completion | 30 October 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- Infantil formula
Conditions studied
- Child Development — all drugs for Child Development →
Sponsor
Institut Pasteur de Lille
Who can join
Adults 1 Day to 21 Days, any sex, with Child Development. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
From birth to 5 months, milk is the essential and unique food of the newborn. The French National Nutrition Program (PNNS) recommends exclusive breastfeeding "up to 6 months and at least 4 months for a healthy benefit". However, only 36% of infants 0-6 months of age are exclusively breastfed worldwide. Some mothers choose to give infant formula to their baby in the first few months of life. This decision may be a personal choice or be imposed by pathophysiological situations. The nutritional requirements of the infant are specific, which implies adequate nutrition. Infant formulas and follow-up formulas are therefore complex products, specially developed for a group of vulnerable consumers. In fact, the compositional and information requirements for infant formula are highly regulated. Even clinical studies are not required to market an infant formula, it is important to obtain objective date on infant growth. Therefore, this study proposes to evaluate the effect of the consumption of an infant formula on the growth of infants from 0 to 6 months in comparison with the growth curves of the World Health Organization (WHO).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02997826
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Child Development
Currently open trials in the same condition.
- NCT07244120 — Embodied Writing Versus Conventional Writing Practice for Handwriting · NA · recruiting
- NCT07244055 — Effects of Animal Fun Program in Children With DCD. · NA · recruiting
- NCT07514377 — JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China · active not recruiting
- NCT07148531 — Caregiver Mental Health and Early Childhood Development in Conflict-Affected Settings · NA · active not recruiting
- NCT06586723 — Impact Trial of Helping Educational Leaders Mobilize Evidence · NA · recruiting
Other Institut Pasteur de Lille trials
Trials by the same sponsor.
- NCT06894251 — Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia · NA · recruiting
- NCT06380218 — Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE) · NA · recruiting
- NCT05306093 — Depressed Mood and Anhedonia in Healthy Adults · NA · completed
- NCT05178667 — Food Supplement Effect on Overweight or Moderate Obesity · NA · completed
- NCT05717491 — Study of Diabetes' Risk Factors and Accelerated Aging According to Socio-economic Status in a Population From the North · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02997826 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut Pasteur de Lille
- Last refreshed: 8 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02997826.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing